Follow
Aneta Mikulasova
Aneta Mikulasova
Research Fellow, Newcastle University, United Kingdom
Verified email at newcastle.ac.uk
Title
Cited by
Cited by
Year
Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma
BA Walker, EM Boyle, CP Wardell, A Murison, DB Begum, NB Dahir, ...
Journal of clinical oncology: official journal of the American Society of …, 2015
5012015
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma
A Mikulasova, CP Wardell, A Murison, EM Boyle, GH Jackson, J Smetana, ...
Haematologica 102 (9), 1617, 2017
772017
Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2
CJA Duncan, BJ Thompson, R Chen, GI Rice, F Gothe, DF Young, ...
Science immunology 4 (42), eaav7501, 2019
572019
Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma
A Mikulasova, C Ashby, RG Tytarenko, P Qu, A Rosenthal, JA Dent, ...
Haematologica 105 (4), 1055, 2020
412020
Germline TET2 loss of function causes childhood immunodeficiency and lymphoma
J Stremenova Spegarova, D Lawless, SMB Mohamad, KR Engelhardt, ...
Blood 136 (9), 1055-1066, 2020
352020
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
B Oben, G Froyen, KH Maclachlan, D Leongamornlert, F Abascal, ...
Nature communications 12 (1), 1-11, 2021
342021
Genomewide profiling of copy‐number alteration in monoclonal gammopathy of undetermined significance
A Mikulasova, J Smetana, M Wayhelova, H Janyskova, V Sandecka, ...
European journal of haematology 97 (6), 568-575, 2016
312016
Gain (1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib
J Smetana, K Berankova, R Zaoralova, P Nemec, H Greslikova, R Kupska, ...
Clinical Lymphoma Myeloma and Leukemia 13 (2), 123-130, 2013
302013
Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience
J Smetana, J Frohlich, R Zaoralova, V Vallova, H Greslikova, R Kupska, ...
BioMed research international 2014, 2014
292014
A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance
V Sandecká, R Hájek, L Pour, I Špička, V Ščudla, E Gregora, J Radocha, ...
European Journal of Haematology 99 (1), 80-90, 2017
112017
Prediction of progression of smouldering into therapy requiring multiple myeloma by easily accessible clinical factors [in 527 patients]
R Hajek, V Sandecka, A Seckinger, I Spicka, V Scudla, E Gregora, ...
Blood, The Journal of the American Society of Hematology 124 (21), 2071-2071, 2014
112014
Dynamics of broad H3K4me3 domains uncover an epigenetic switch between cell identity and cancer-related genes
M Belhocine, M Simonin, JDA Flores, A Cieslak, I Manosalva, L Pradel, ...
Genome Research 32 (7), 1328-1342, 2022
72022
Analysis of B-cell subpopulations in monoclonal gammopathies
P Všianská, L Říhová, T Varmužová, R Suská, F Kryukov, A Mikulášová, ...
Clinical Lymphoma Myeloma and Leukemia 15 (4), e61-e71, 2015
62015
Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH
J Smetana, E Dementyeva, F Kryukov, P Nemec, H Greslikova, R Kupská, ...
Neoplasma 61 (1), 48-55, 2014
62014
High-resolution simulations of chromatin folding at genomic rearrangements in malignant B cells provide mechanistic insights into proto-oncogene deregulation
D Rico, D Kent, N Karataraki, A Mikulasova, R Berlinguer-Palmini, ...
Genome Research 32 (7), 1355-1366, 2022
42022
A de novo paradigm for male infertility
MS Oud, RM Smits, HE Smith, FK Mastrorosa, GS Holt, BJ Houston, ...
Nature communications 13 (1), 1-10, 2022
42022
Whole genome sequencing provides evidence of two biologically and clinically distinct entities of asymptomatic monoclonal gammopathies: progressive versus stable myeloma …
B Oben, G Froyen, KH Maclachlan, D Leongamornlert, F Abascal, ...
BioRxiv, 2020
42020
Chromothripsis and chromoplexy are associated with DNA instability and adverse clinical outcome in multiple myeloma
C Ashby, MA Bauer, Y Wang, CP Wardell, RG Tytarenko, P Patel, E Flynt, ...
Blood 132, 408, 2018
42018
Exome sequencing to define a genetic signature of plasma cells in systemic AL amyloidosis
EM Boyle, BA Walker, D Rowczienio, CP Wardell, A Murison, ...
Blood 124 (21), 726, 2014
42014
Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers
A Mikulasova, D Kent, M Trevisan-Herraz, N Karataraki, KTM Fung, ...
Genome Research 32 (7), 1343-1354, 2022
22022
The system can't perform the operation now. Try again later.
Articles 1–20